Latest News in the pharma Industry

Research & Development

First Treatment Approved Under EAMS Developed Using Antibody Humanization Expertise at UK’s MRC Technology

First Treatment Approved Under EAMS Developed Using Antibody Humanization Expertise at UK’s MRC Technology

11 Mar 2015

Read more 
Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of Anti-PD-1 Therapy

Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of Anti-PD-1 Therapy

9 Mar 2015

Read more 
AOP Orphan Pharmaceuticals Announces Progress of Pivotal Phase III Trial PROUD-PV

AOP Orphan Pharmaceuticals Announces Progress of Pivotal Phase III Trial PROUD-PV

6 Mar 2015

Read more 
BMS Signs Exclusive Agreement with Bavarian Nordic for Prostvac, a Prostate-Specific Antigen-Targeting Cancer Immunotherapy

BMS Signs Exclusive Agreement with Bavarian Nordic for Prostvac, a Prostate-Specific Antigen-Targeting Cancer Immunotherapy

4 Mar 2015

Read more 
NIH-Led Effort Launches Big Data Portal for Alzheimer’s Drug Discovery

NIH-Led Effort Launches Big Data Portal for Alzheimer’s Drug Discovery

4 Mar 2015

Read more 
MRC Technology Launches Respiratory ‘Call for Targets’

MRC Technology Launches Respiratory ‘Call for Targets’

2 Mar 2015

Read more 
Acceleron Presents Encouraging Response Rates and Progression-Free Survival Data in Patients with Advanced Renal Cell Carcinoma

Acceleron Presents Encouraging Response Rates and Progression-Free Survival Data in Patients with Advanced Renal Cell Carcinoma

2 Mar 2015

Read more 
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase III Alprolix Pediatric Study

Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase III Alprolix Pediatric Study

27 Feb 2015

Read more 
Rigel and BMS Announce R&D Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications

Rigel and BMS Announce R&D Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications

26 Feb 2015

Read more 
Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro

Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro

25 Feb 2015

Read more 
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status

New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status

23 Feb 2015

Read more 
NIH-Funded Scientists Create Potential Long-Acting HIV Therapeutic

NIH-Funded Scientists Create Potential Long-Acting HIV Therapeutic

20 Feb 2015

Read more